Journal article
Menopause, hysterectomy, menopausal hormone therapy and cause-specific mortality: cohort study of UK Biobank participants
Z Xu, HF Chung, AJ Dobson, LF Wilson, M Hickey, GD Mishra
Human Reproduction | OXFORD UNIV PRESS | Published : 2022
Abstract
STUDY QUESTION: What is the association between menopausal hormone therapy (MHT) and cause-specific mortality? SUMMARY ANSWER: Self-reported MHT use following early natural menopause, surgical menopause or premenopausal hysterectomy is associated with a lower risk of breast cancer mortality and is not consistently associated with the risk of mortality from cardiovascular disease or other causes. WHAT IS KNOWN ALREADY: Evidence from the Women's Health Initiative randomized controlled trials showed that the use of estrogen alone is not associated with the risk of cardiovascular mortality and is associated with a lower risk of breast cancer mortality, but evidence from the Million Women Study s..
View full abstractGrants
Awarded by National Health and Medical Research Council
Funding Acknowledgements
This research is supported by the Australian National Health and Medical Research Council (NHMRC) (grant numbers APP1027196 and APP1153420). ZX and LFW are supported by NHMRC Centre for Research Excellence (APP1153420) and GDM is supported by NHMRC Principal Research Fellowship (APP1121844). MH is supported by an NHMRC Investigator Grant (APP1193838). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.